Articles On Polynovo (ASX:PNV)

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Tuesday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 1.39% t...

Shares in Polynovo Ltd (ASX: PNV) have rocketed out of a trading halt this morning by more than 12%. Here’s what you need to know. About Polynovo Ltd PolyNovo is an Australian medical device company that designs, develops, and manufactures...

In afternoon trade the S&P/ASX 200 index is pushing notably higher. At the time of writing the benchmark index is up 1.2% to 6,814.7 points. Four shares that are climbing more than most today are listed below. Here’s why they are storm...

PolyNovo (PNV) has reported $2 million in revenue for December 2019 – marking its first month of bringing in this amount The figure represents a 134 per cent increase compared to the December 2018 period While pleased with the achievement,...

The PolyNovo Ltd (ASX: PNV) share price has been a strong performer on Tuesday. The medical device company’s shares raced as much as 12% higher after returning from a trading halt this morning. They have since pulled back a touch, but are...

In 2019, the S&P/ASX 200 (INDEXASX: XJO) increased nearly 22%. Avita Medical Ltd (ASX: AVH) was the star performer on the index, up more than 700% for the year. Polynovo Ltd (ASX: PNV), EML Payments Ltd (ASX: EML), and Fortescue Metals...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Wednesday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 0.20%...

In afternoon trade the S&P/ASX 200 index is on course to start the year on a positive note. At the time of writing the benchmark index is up 0.2% to 6,698.6 points. Four shares that have failed to follow the market higher today are lis...

The S&P/ASX 200 index has started the year on a mildly positive note. At lunch the benchmark index is trading 0.1% higher at 6,692.5 points. Here’s what has been happening on the market today: Afterpay pushes higher.       The Afterpay...

The S&P/ASX 200 index was in fine form in 2019, ending the year with a return of just over 20% excluding dividends. Whilst the majority of shares on the index raced higher, a number climbed more than most. Here’s why these were the bes...

It’s been a good year for healthcare shares in 2019. Led by CSL Limited (ASX: CSL), the S&P/ASX 200 Healthcare Index (ASX: XHJ) is up over 42% for the year. We take a look at 3 ASX healthcare shares that have delivered healthy returns...

At every investor presentation – and he’s fronted a few – Avita Medical (ASX:AVH) chief executive Dr Mike Perry includes a before-and-after picture of the visage of a 12-year-old girl who suffered burns to two-thirds of her body when her fa...

The CogState Limited (ASX: CGS) share price surged after the brain health testing company reported a record level of sales contracts. The CGS share price jumped 30% to 39 cents during lunch time trade when the All Ordinaries (Index:^AORD)...

The S&P/ASX 200 index closed higher, up by 4.1 points or 0.06 per cent at 6,851.4 points relative to the last close. And, the All Ordinaries index closed higher by 0.09 per cent or 6.5 points to close at 6,957 points. Some of the best...

Earlier today I looked at three ASX 200 shares that have been smashed in 2019. Thankfully, these shares are in the minority, with the majority of shares on the index recording solid gains this year. Three ASX 200 shares that are leading th...

PolyNovo (ASX:PNV) has announced that NovoSorb BTM has been granted a certificate of conformance (CE Mark) approval for sale throughout UK/Ireland and the European Union.

PolyNovo (PNV) is helping those injured in the White Island volcano eruption by suppling its burn repair product, NovoSorb BTM, to local hospitals The company has supplied its product to three hospitals in New Zealand and two in Australia...

The Australian market traded in green zone on December 13, 2019 and S&P/ASX 200 closed at 6739.7 with a rise of 30.9 points or 0.5% on an intraday basis. Let us now have a look at the performance of some sectors. On December 13, 2019, S...

  The S&P/ASX 200 index closed higher, up by 30.9 points or 0.46 per cent at 6,739.7 points relative to the last close. And, the All Ordinaries index closed higher by 0.49 per cent or 33.8 points to close at 6,844.6 points. Some of the...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Friday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 0.46% to...

The S&P/ASX 200 index is on course to finish the week on a high. In afternoon trade the benchmark index is up 0.6% to 6,747.8 points. Four shares that are climbing more than most today are listed below. Here’s why they are ending the w...

PolyNovo Limited (ASX: PNV), an Australian based medical company, has received approval to sell its NovoSorb BTM product throughout the European Union and UK/Ireland. NovoSorb BTM is a dermal scaffold for the regeneration of dermis when l...

The Polynovo Ltd (ASX: PNV) share price is ending the week on a very positive note. In early afternoon trade the medical device company’s shares are the best performers on the ASX 200 with a 17.5% gain to $2.04. At one stage the Polynovo s...

At lunch on Friday the S&P/ASX 200 index is on course to finish the week on a high. The benchmark index is up 0.5% to 6,740.5 points. Here’s what has been happening on the market today: Bank shares higher.  Australia’s big four banks a...

The performance of Australian equities is sensitive to the broader macro-economic environment and to the health of global economy. In the event of economic slowdown, the investors tend to make deployments towards safer asset classes, and th...

The S&P/ASX 200 index closed lower, down by 43.8 points or 0.65 per cent at 6,708.8 points relative to the last close. The All Ordinaries index closed lower by 0.62 per cent or 42.4 points to close at 6,810.8 points. Some of the best &...

The S&P/ASX 200 index closed higher, up 45.7 points or 0.68 per cent at 6,752.6 points relative to the last close. And, the All Ordinaries index closed higher by 0.6 per cent or 41.1 points to close at 6,853.2 points. Some of the best...

Health care system in Australia ranks well internationally with the presence of big pharmaceutical companies. With the push created by improvements in medical technology, such as advances in diagnostic and therapeutic-new radiological scann...

The holiday season is here and there are a lot of chances that Christmas Rally would be witnessed this year as well. The Santa Claus Rally or Christmas Rally defines a constant rise in the share market that happens in the final week, during...

The S&P/ASX 200 index closed slightly lower, ending 18 points or 0.26 per cent lower at 6846.0 points relative to the last close. All Ordinaries index shed 0.25 per cent or 17.6 points to close at 6,948.0 points.  Some of the best &amp...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Friday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 0.26% to 6...

The best performer on the ASX 200 index this year has been the AVITA Medical Ltd (ASX: AVH) share price. Since the start of the year the global regenerative medicine company’s shares have gained a remarkable 686%. The next best performers...

The S&P/ASX 200 index broke closing record for the second-day running, ending 13.4 points or 0.2 per cent higher at 6864.0 points relative to the last close. All Ordinaries index firmed up 0.22 per cent or 15 points to close at 6,965.6...

In the Australian health care sector, the advancement in medical science have completely changed the health care services. New and advanced technologies have a high impact on medical and health services. These technologies are improving the...

The stock markets in Australia are sensitive to macro-economic factors as well as to the health of global economy. On November 25, 2019. S&P/ASX200 ended the session in green. Reflecting a rise of 21.6 points, the index stood at 6731.4....

Health care sector is one of the most significant contributors to the Australian economy, known for delivering best services by advancing technology. Health care sector comprises of providers of medical services, medical insurance, and medi...

Thursday was another disappointing day on the ASX 200 as the benchmark index fell 0.74% lower. The S&P/ASX 200 Index (INDEXASX: XJO) shed 49.50 points to close at 6,672.90 points yesterday. Leading the losses were healthcare, mining an...

The S&P/ASX 200 Index continued its losing streak for the second day running, shedding 0.7 % or 49.5 point to close at 6,672.9 points. All Ordinaries index also finished 0.7 % or 50.6 points lower at 6777.7 points. Markets have reacted...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Friday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 0.87% to...

In the share market past performance is no guide to future returns as the disclaimer goes. However, it can often be instructive. While on a risk-adjusted basis mid-cap or growth-style shares are often the best bet for growth. This is becau...

The young adults of 21st century are confident, ambitious, and achievement-oriented while carrying various array of interests and hobbies. The previous generation people struggled for owning a house, but the youth of the modern times is att...

In the present age of digitization, digital health service sector has surfaced as one of the fastest-growing industries. Introduction of technologies in the health care domain has completely transformed the sector and has emerged out as a b...

Australia’s health care industry is one of the fastest growing industries in the country that is making substantial progress driven by new technological advancements. The country’s government is injecting billions of dollars into modernisin...

With the S&P/ASX200 (ASX: XJO) index yesterday closing at 6,697 points (just shy of the all-time high hit in July), it’s safe to say we are seeing stocks at robust and healthy valuations across the board. Although for anyone with a hea...

Melbourne-based PolyNovo (ASX:PNV) has been named ‘Company of the Year’ while Perth medical device company, OncoRes Medical, has been named 'Emerging Company of the Year 'at the 2019 AusBiotech and Johnson & Johnson Innovation I...

In recent years, Australia’s health care industry has remarkably grown in terms of size and reputation for its world-leading technology, advanced R&D, innovation, leading scientists and health care professionals. Australia is one of the...

The healthcare sector can be viewed with high scepticism as it’s difficult to invest without being a subject matter expert. But with this high barrier to entry comes a huge opportunity to capture alpha. To make it easier for you, I’ve put...

ASX listed healthcare shares make up a popular defensive investment sector. Most people will devote significant resources to their health and the health of their loved ones over their lifetime. Trends including the aging population, obesit...

A $100 million plus contract doesn’t take you as far as it used to. The Austal Limited (ASX: ASB) share price gave up morning gains even after the shipbuilder announced that it’s been awarded a large ferry contract. The Austal share price...

A growth stock is generally referred to a share of a company which is expected to witness a growth at a higher rate in comparison to the market average. These types of stocks do not usually provide a return in the form of dividends. These c...